[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"EUROS\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100623934","post-market-clinical-follow-up-study-of-nemost-v2-100623934",false,"NCT07403084","Post-market Clinical Follow-up Study of NEMOST V2","Post-market Clinical Follow-up Study of NEMOST V2 Growing Domino","NEMOST V2","Inclusion Criteria:\n\n* Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring primary surgical intervention.\n* The patient, as well as their parents or legal guardians, are informed of the participation in the study.\n* Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth\n\nExclusion Criteria:\n\n* signs of local inflammation;\n* acute or chronic, local or systemic infections ;\n* non-reducible scoliosis ;\n* pathological obesity ;\n* allergy or intolerance to implanted materials;\n* insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused.","ALL","5 Years","17 Years",{"count":21,"type":22},140,"ESTIMATED","INTERVENTIONAL",[25],"NA","The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.\n\nAs part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.\n\nRetrospective and prospective multicenter post-market surveillance clinical study.\n\nThis study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.\n\nThe secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.\n\nThe study will include 140 patients.",[28,29,30],"Scoliosis Neuromuscular","Scoliosis Idiopathic","Consent Forms","RECRUITING","2026-02-04",{"date":34,"type":35},"2026-02-11","ACTUAL",{"date":37,"type":35},"2025-12-19",{"date":39,"type":22},"2033-12-19",{"name":41,"class":42},"EUROS","INDUSTRY",5,""]